Atlas Trials

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Clinical trial NCT01094964 · UNKNOWN

Trial details

NCT number
NCT01094964
Sponsor
Cancer Research Campaign Clinical Trials Centre
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2009-10-01
Primary completion
2013-10-01
Enrollment
242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.